Luis-de-Luzuriaga-BIT

Irvine, USA, July 25, 2018 – BIT is glad to announ­ce that Luis de Luzuriaga will be taking on with imme­dia­te effect the role as Global CEO for BIT Group.

It is BIT’s plea­su­re to announ­ce that Luis de Luzuriaga will be taking on with imme­dia­te effect the role as Global CEO for BIT Group. Luis has been with BIT for three mon­ths ser­ving as the CEO for BIT USA. Prior to joi­ning BIT USA, he was the GM and Divisional VP of Abbott Hematology and has pre­vious­ly worked for Leica Biosystems, a Danaher com­pa­ny, Siemens and Bayer.

Luis brings a wealth of expe­ri­ence in our rele­vant indus­try and throughout the ent­i­re value chain. BIT is very plea­sed to be able to bring him on board and wish him all the best of suc­cess for our joint future. Luis will retain his role as CEO of BIT USA and will work out of the Irvine, CA office.

Luis will lead the con­ti­nua­ti­on of BIT’s joint jour­ney to deve­lop BIT to be the most inno­va­ti­ve, effec­tive and reli­able part­ner to deve­lop, manu­fac­tu­re and ser­vice medi­cal dia­gnostic devices. To achie­ve this, he will con­ti­nue to dri­ve the blue cul­tu­re and the align­ment of cul­tures across BIT glo­bal­ly. He and the BIT Leadership Team will work tog­e­ther in the com­ing mon­ths to build upon the stra­te­gy work star­ted in January.

BIT pro­vi­des con­tract pro­duct deve­lop­ment, manu­fac­tu­ring and after-sales ser­vices, as well as hema­to­lo­gy instru­ments for life sci­ence, medi­cal and IVD instru­men­ta­ti­on OEMs. Quality and regu­lato­ry stan­dards inclu­de GMP, FDA regis­te­red, ISO13485, QSR and CE IVD Directive. BIT’s glo­bal ope­ra­ti­ons in USA, Germany, France and China deli­ver pre­cisi­on engi­nee­red, cost effec­tive sys­tems solu­ti­ons. With our cli­ents, we BUILD INNOVATION TOGETHER.

Contact:

Valentin Kaiser
Global Marketing Manager
Phone: +1 (858) 886 8350
V.Kaiser@BIT-Group.com
www.BIT-Group.com